Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Feb;123(1):231-232.
doi: 10.1007/s13760-020-01592-z. Epub 2021 Jan 8.

Effect of phosphatidic acid on antiganglioside antibody reactivity in the isolated facial diplegia variant of Guillain-Barré syndrome: a case report

Keiichi Nakahara  1   2 , Shunya Nakane  3 , Tadashi Terasaki  4 , Yukio Ando  3
Affiliations
Case Reports

Effect of phosphatidic acid on antiganglioside antibody reactivity in the isolated facial diplegia variant of Guillain-Barré syndrome: a case report

Keiichi Nakahara et al. Acta Neurol Belg. 2023 Feb.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Yuki N, Hartung HP (2012) Guillain–Barré syndrome. N Engl J Med 366:2294–2304 - DOI - PubMed
    1. Wakerley BR, Unici A, Yuki N (2014) GBS classification group. Guillain–Barré and Miller Fisher syndromes—new diagnostic classification. Nat Rev Neurol 10:537–544 - DOI - PubMed
    1. Tan EK, Lim SH, Wong MC, Chan LL (1999) Facial diplegia: cranial variant of Guillain–Barré syndrome? J R Soc Med 92:26–27 - DOI - PubMed - PMC
    1. Susuki K, Koga M, Hirata K, Isogai E, Yuki N (2009) A Guillain–Barré syndrome variant with prominent facial diplegia. J Neurol 256:1899–1905 - DOI - PubMed
    1. Kim JK, Oh SY, Shon EH, Hong YH, Jun SM, Bae JS (2015) When is facial diplegia regarded as a variant of Guillain–Barré syndrome? J Peripher Nerv Syst 20:32–36 - DOI - PubMed

Grants and funding

LinkOut - more resources